News · Science News; Stanford spent more than 20 years developing a blood-cancer transplant therapy; its first commercial patient has now been ... This GujjuTicks brief summarizes the headline for local readers; read the full story on the publisher site.
This is a short GujjuTicks summary for discovery. Full reporting and quotes belong to the original publisher.